It is well recognised that microsomal mixed function oxidase enzymes are important in the biotransformation of xenobiotics into carcinogens. In experimental animal models of liver cancer, potent inducers of mixed function oxidative enzymes, such as phenobarbitone and polychlorinated biphenols, act as promoters of carcinogenesis.2 We examined the rate of oxidative metabolism in vivo in African patients with hepatocellular carcinoma in the Sudan and in normal healthy subjects by measurement of antipyrine (phenazone) elimination. Antipyrine elimination rate in vivo has been shown to correlate with the activity of hepatic mixed function oxidative enzymes in vitro.3
Methods

PATIENTS
Ten patients with biopsy proven hepatocellular carcinoma, but without histological or clinical evidence of concurrent cirrhosis were selected for this study. The 10 normal subjects were matched for age and sex. Both groups were screened for but found not to have schistosomiasis, amoebiasis, and malaria. Serum was taken and frozen at -20(C for Address for corrcsponidence: Dr 
Results
The results of antipyrine kinetics in patients and normals are given in the Table. Mean values for antipyrine t½/2, V and CL were 7%, 16%, and 8%, respectively, lower in patients compared with normal subjects. These differences did not achieve statistical significance (Table) . Correction of antipyrine clearance for weight increased the similarity between the two groups: 29-5±12-9 (mean±SD) ml/h/kg in patients and 287±+11-6 in normal subjects. There was no correlation between serum albumin and antipyrine clearance (r=0-145, p=054), antipyrine clearance corrected for body weight (r=0.062, p=0.80), antipyrine half life (r=0-038, p=087) or antipyrine volume of distribution (r=0349, p=0 13).
The weight, serum bilirubin and serum globulin were similar in the two groups. Patients had significantly higher serum alkaline phosphatase (patients 43-9±40-7, normal subjects 7-7±7-2 KingArmstrong units) and aspartate aminotransferase (patients 34-8±35-6, normal subjects 10-3±7 1 IU/l). The serum albumin was 29-9±7-4 g/l in patients and 43-9±4 6 g/l in normal subjects. Six patients with hepatocellular carcinoma had a serum albumin value less than 35 g/l. All normal subjects had serum albumin values in the normal range.
Two patients only had raised alpha fetoprotein The present study shows that there is no major difference in overall oxidative metabolism in patients with hepatocellular carcinoma when compared with normal adults in the Sudan. It is evident, however, that this study measured oxidative metabolism after diagnosis of hepatocellular carcinoma. Thus the absence of such a difference at the time of diagnosis does not exclude the possibility of increased mixed function oxidative enzyme activity before presentation which may have resulted in carcinogen production and led to the development of hepatocellular carcinoma. As a consequence, repeated observations of mixed function oxidative activity in a representative sample of a population with a high incidence of hepatocellular carcinoma may be necessary. It is possible that more subtle differences in oxidative metabolism exist than can be ascertained by antipyrine elimination. Recognition of the multiplicity of cytochrome P-450 dependent mixed function oxidative iosenzymes13 suggests that determination of specific polymorphisms in human drug metabolism 9 in a population at risk may unravel the contribution of genetic and environmental influences on hepatic carcinogenesis. 
